Intravenous administration of the conditionally replicative adenovirus Ad5-Δ24RGD induces regression of osteosarcoma lung metastases
2008

Adenovirus Treatment for Osteosarcoma Lung Metastases

Sample size: 12 publication Evidence: moderate

Author Information

Author(s): Graat Harm CA, van Beusechem Victor W, Schagen Frederik HE, Witlox M Adhiambo, Kleinerman Eugenie S, Helder Marco N, Gerritsen Winald R, Kaspers Gertjan JL, Wuisman Paul IJM

Primary Institution: VU University medical center

Hypothesis

Can intravenous administration of the conditionally replicative adenovirus Ad5-Δ24RGD suppress the growth of human osteosarcoma lung metastases?

Conclusion

Intravenous administration of Ad5-Δ24RGD shows promise as a new treatment strategy for metastatic osteosarcoma by reducing tumor burden in the lungs.

Supporting Evidence

  • The number of lung tumor nodules was significantly reduced in treated mice compared to controls.
  • Mice treated with the adenovirus showed increased body weight gain, indicating improved health.
  • Adenovirus infection was detected in lung tumor nodules, suggesting ongoing viral activity.

Takeaway

Researchers tested a virus that can kill cancer cells in mice with lung tumors from bone cancer, and it helped shrink the tumors.

Methodology

Mice with osteosarcoma lung metastases were treated with the adenovirus or a control solution, and their lung weights and tumor nodules were measured.

Limitations

Mice were not completely cured from their osteosarcoma lung metastases, indicating the need for further treatment strategies.

Participant Demographics

Female athymic/nude/nude mice were used in the experiments.

Statistical Information

P-Value

p<0.005

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1476-4598-7-9

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication